PF-00835231 |
Catalog No.GC62133 |
PF-00835231 es un inhibidor de la proteasa similar a la cisteÍna 3C (3CLpro) de CoV-2, con IC50 de 0,27 nM y 4 nM para SARS CoV-2 y SARS CoV-1 3CLpro, respectivamente.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 870153-29-0
Sample solution is provided at 25 µL, 10mM.
PF-00835231 is a CoV-2 cysteine 3C-like protease (3CLpro) inhibitor, with IC50s of 0.27 nM and 4 nM for SARS CoV-2 and SARS CoV-1 3CLpro, respectively. PF-00835231 is developed for the research of anti-SARS-CoV-2/COVID-19[1].
[1]. Robert L Hoffman, et al. Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19. J Med Chem. 2020 Nov 12;63(21):12725-12747.
Average Rating: 5
(Based on Reviews and 34 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *